Serum levels of AZGP1, best known as a marker in cancer progression, were demonstrated in a small study to be increased in the early phase of AKI, and high initial levels of AZGP1 correlated with extra-renal complications but not with parameters of renal function.24 Here, AZGP1 is linked to cancer.